(Q33914835)

English

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A randomised controlled trial of antiplatelet therapy in combination with Rt-PA thrombolysis in ischemic stroke: rationale and design of the ARTIS-Trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

5

object named as

Y B Roos

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

S M Zinkstok

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

M Vermeulen

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J Stam

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

R J de Haan

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ARTIS study group

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

12 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

51

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

copyright license

Creative Commons Attribution 2.0 Generic

12 May 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

https://scigraph.springernature.com/pub.10.1186/1745-6215-11-51

0 references

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the A

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Usefulness of checking platelet count before thrombolysis in acute ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

The Academic Medical Center Linear Disability Score (ALDS) item bank: item response theory analysis in a mixed patient population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Thrombolysis for acute ischaemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Acetylsalicylic acid pretreatment, concomitant heparin therapy and the risk of early intracranial hemorrhage following systemic thrombolysis for acute ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Streptokinase in acute ischemic stroke: an individual patient data meta-analysis : The Thrombolysis in Acute Stroke Pooling Project

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Tissue plasminogen activator for acute ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

5 July 2018

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

The impact of recanalization on ischemic stroke outcome: a meta-analysis

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: a multicenter transcranial Doppler study.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.

1 reference

https://api.crossref.org/works/10.1186%2F1745-6215-11-51

21 January 2018

Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2886039

29 October 2018

Time Course of Tissue Plasminogen Activator–Induced Recanalization in Acute Cardioembolic Stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Race and prognosis after myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changes in coagulation and fibrinolysis markers in acute ischemic stroke treated with recombinant tissue plasminogen activator

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Cologne stroke experience: safety and outcome in 450 patients treated with intravenous thrombolysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fast platelet suppression by lysine acetylsalicylate in chronic stable coronary patients. Potential clinical impact over regular aspirin for coronary syndromes

1 reference

https://pubmed.ncbi.nlm.nih.gov/20459856

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1745-6215-11-51

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/1745-6215-11-51

9 September 2019

release_prrfdsn5kjdyroz6xx3r3bkngm

1 reference

https://api.fatcat.wiki/v0/release/prrfdsn5kjdyroz6xx3r3bkngm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33914835&oldid=1978967986"